Immune Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Immune Therapeutics's balance sheet done over the years? Its assets were worth $963,719 last year, which is less than in the previous period. 361% of Immune Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $3,477,173, which means an decrease by -69% compared compared to last year.
Debt to Assets
| 2013 | 19192086 | 2.56M | 13.34% |
|---|---|---|---|
| 2014 | 6054990 | 3.70M | 61.15% |
| 2015 | 41228 | 5.99M | 14551.79% |
| 2016 | 76439 | 9.20M | 12036.77% |
| 2017 | 195545 | 11.29M | 5778.17% |
| 2018 | 91626 | 11.34M | 12378.87% |
| 2019 | 5816 | 13.69M | 235461.43% |
| 2020 | 10171 | 11.67M | 114808.3% |
| 2021 | 3138885 | 11.08M | 353.22% |
| 2022 | 963719 | 3.47M | 360.81% |
IMUN Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 150.49K | 493.88K | 9.97K | 4.92K | 5.85K | 14.71K | 74.38K | 23.14K | 191.98K | 406.59K |
Short term investments | 0 | 2.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.19K | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 82.80K | 178.09K | 0 | 0 | 0 | 0 |
Other current assets | 0 | 2.64B | 0 | 0 | 0 | 0 | 0 | 0 | 30K | 215.9K |
Total current assets | 150.49K | 3.13M | 9.97K | 4.92K | 88.66K | 192.81K | 74.38K | 39.34K | 221.98K | 622.49K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 0 | 0 | 0 | 691 | 2.76K | 2.52K | 1.85K | 1.68K | 4.23K | 5.60K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 762.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.81M | 18.54M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 50.72K | 0 | 200 | 200 | 200 | 200 | 200 | 200 | 10.18K | 17.43K |
Total non-current assets | 813.22K | 0 | 200 | 891 | 2.96K | 2.72K | 2.05K | 1.88K | 5.83M | 18.56M |
Total assets | 963.71K | 3.13M | 10.17K | 5.81K | 91.62K | 195.54K | 76.43K | 41.22K | 6.05M | 19.19M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 5.11M | 5.01M | 4.69M | 3.30M | 2.48M | 0 | 0 | 0 | 664.27K |
Short term debt | 696.47K | 3.07M | 2.84M | 5.54M | 5.18M | 4.82M | 4.22M | 2.79M | 186.06K | 817.19K |
Total current liabilities | 3.47M | 11.08M | 11.67M | 13.69M | 11.34M | 11.29M | 9.20M | 5.99M | 3.37M | 2.43M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 327.45K | 121.12K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 1.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities | 1.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 327.45K | 121.12K |
Total liabilities | 3.47M | 11.08M | 11.67M | 13.69M | 11.34M | 11.29M | 9.20M | 5.99M | 3.70M | 2.56M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |